These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 7794217)
1. Serotonin and drug-induced movement disorders. Sachdev P Aust N Z J Psychiatry; 1994 Dec; 28(4):695-6. PubMed ID: 7794217 [No Abstract] [Full Text] [Related]
2. Drug-induced movement disorders. Gershanik OS Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509 [TBL] [Abstract][Full Text] [Related]
3. [Neuroleptics and serotonin]. Hery F; Hamon M Encephale; 1993; 19(5):525-32. PubMed ID: 7905821 [TBL] [Abstract][Full Text] [Related]
4. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia]. Guise S; Soubrouillard C; Blin O Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300 [TBL] [Abstract][Full Text] [Related]
5. Functional consequences of dopaminergic degeneration in Parkinson's disease. Tedroff JM Adv Neurol; 1999; 80():67-70. PubMed ID: 10410704 [No Abstract] [Full Text] [Related]
6. Neurobiological aspects of social anxiety disorder. Furmark T Isr J Psychiatry Relat Sci; 2009; 46(1):5-12. PubMed ID: 19728568 [TBL] [Abstract][Full Text] [Related]
7. Advances in understanding the neural mechanisms underlying L-DOPA-induced dyskinesia. Brotchie JM Adv Neurol; 1999; 80():71-85. PubMed ID: 10410705 [No Abstract] [Full Text] [Related]
15. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease. Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492 [TBL] [Abstract][Full Text] [Related]
16. Dopamine D2-like receptors and the antidepressant response. Gershon AA; Vishne T; Grunhaus L Biol Psychiatry; 2007 Jan; 61(2):145-53. PubMed ID: 16934770 [TBL] [Abstract][Full Text] [Related]
17. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications. Ba M; Kong M; Ma G; Yang H; Lu G; Chen S; Liu Z Brain Res; 2007 Jan; 1127(1):177-84. PubMed ID: 17113046 [TBL] [Abstract][Full Text] [Related]
18. Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias. Carta M; Carlsson T; Muñoz A; Kirik D; Björklund A Prog Brain Res; 2008; 172():465-78. PubMed ID: 18772046 [TBL] [Abstract][Full Text] [Related]